Less Ads, More Data, More Tools Register for FREE

Pin to quick picksRXB.L Regulatory News (RXB)

  • There is currently no data for RXB

Holding(s) in Company

10 Aug 2015 14:30

RNS Number : 6110V
Rex Bionics PLC
10 August 2015
 

 

For filings with the FSA include the annex

For filings with issuer exclude the annex

 

 

TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARESi

 

 

1. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attached: ii

 

 

Rec Bionics PLC (RXB.LN)

2 Reason for the notification (please tick the appropriate box or boxes):

 

An acquisition or disposal of voting rights

 

ü

An acquisition or disposal of qualifying financial instruments which may result in the acquisition of shares already issued to which voting rights are attached

An acquisition or disposal of instruments with similar economic effect to qualifying financial instruments

 

An event changing the breakdown of voting rights

Other(please specify):

 

 

3. Full name of person(s) subject to the notification obligation: iii

 

 

 

NEW ZEALAND VENTURE INVESTMENT FUND LIMITED

 

 

4. Full name of shareholder(s)

(if different from 3.):iv

 

 

 

5. Date of the transaction and date on

which the threshold is crossed or reached: v

 

01 July 2015

 

6. Date on which issuer notified:

 

 

12 July 2015 2015

7. Threshold(s) that is/are crossed or reached: vi, vii

 

Variation of Holding of more than 3%.

 

8. Notified details:

A: Voting rights attached to shares viii, ix

Class/type of shares

 

if possible using the ISIN CODE

Situation previous to the triggering transaction

Resulting situation after the triggering transaction

Number

of

Shares

Number

of Voting Rights

Number

of shares

Number of voting

rights

% of voting rights x

 

Direct

xi

Direct

xii

Indirect

 

Direct

 

Indirect

 

GB00BLRLQM66

1,406,673

1,406,673

7.89%

 

 

B: Qualifying Financial Instruments

 

Resulting situation after the triggering transaction

Type of financial

instrument

Expiration date xiii

Exercise/

Conversion Period xiv

Number of voting

rights that may be acquired if the instrument is exercised/ converted.

% of voting

rights

 

 

C: Financial Instruments with similar economic effect to Qualifying Financial Instruments

xv, xvi

 

Resulting situation after the triggering transaction

Type of financial

instrument

Exercise

price

Expiration date xvii

Exercise/

Conversion period xviii

Number of voting rights

instrument refers to

% of voting rights xix,

xx

 

Nominal

 

Delta

 

 

 

Total (A+B+C)

Number of voting rights

Percentage of voting rights

1,429,677

7.89%

9. Chain of controlled undertakings through which the voting rights and/or the financial instruments are effectively held, if applicable: xxi

 

 

 

 

 

Holder of Voting

Rights

Person registered and

entitled to be Registered as

Holder

Nature of Voting Rights & Control

N/A

 

 

 

Proxy Voting:

 

10. Name of the proxy holder:

 

11. Number of voting rights proxy holder will cease to hold:

 

12. Date on which proxy holder will cease to hold voting rights:

 

 

 

 

13. Additional information:

 

14. Contact name:

Aaron Tregaskis

 

 

15. Contact telephone number:

09 951 0170 (NZ)

 

Note: Annex should only be submitted to the FSA not the issuer

 

Annex: Notification of major interests in sharesxxii

 

 

 

 

A: Identity of the persons or legal entity subject to the notification obligation

Full name

(including legal form of legal entities)

Contact address

(registered office for legal entities)

Phone number & email

Other useful information

(at least legal representative for legal persons)

 

 

 

B: Identity of the notifier, if applicable

Full name

Contact address

Phone number & email

Other useful information

(e.g. functional relationship with the person or legal entity subject to the notification obligation)

 

C: Additional information

 

 

 

 

 

 

 

 

For notes on how to complete form TR-1 please see the FSA website.

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
HOLBXGDIIGBBGUG
12
Date   Source Headline
30th May 20177:30 amRNSSuspension - Rex Bionics Plc
26th May 20174:31 pmRNSHolding(s) in Company
26th May 20177:00 amRNSCompletion of Business Transfer & Refinancing
25th May 201710:39 amRNSHoldings in Company
25th May 201710:38 amRNSHoldings in Company
22nd May 201712:23 pmRNSResults of General Meeting
3rd May 20177:00 amRNSRestructuring and New Investment
13th Mar 20177:00 amRNSFunding and strategic review update
23rd Jan 20177:00 amRNSREX initiates RAPPER III MS clinical trial
5th Dec 20167:00 amRNSInterim Results for six months ending 30 Sept 2016
18th Nov 20167:00 amRNSPresentation of REX Case Report at SCI Conference
7th Nov 20169:47 amRNSPositive Update from Rapper II Clinical Trial
24th Oct 20167:00 amRNSStroke & Brain Injury Clinical Trial in Australia
27th Sep 20161:00 pmRNSDirectors Interests
27th Sep 201612:57 pmRNSResults of Annual General Meeting
19th Sep 201610:57 amRNSRetirement of Director
1st Sep 20165:42 pmRNSPosting of Annual Report and Accounts
26th Aug 20167:00 amRNSAudited results for the year ended 31 March 2016
18th Aug 20167:00 amRNSMore Positive Data from RAPPER II
5th Aug 20162:14 pmRNSConfirmation of Strategic Investment by Maxhealth
1st Aug 201610:36 amRNSResults of General Meeting
22nd Jul 201612:00 pmRNSPosting of Supplementary Circular
18th Jul 20167:00 amRNSProposed Fundraising & General Meeting Adjournment
29th Jun 20169:30 amRNSProposed Fundraising and Notice of General Meeting
18th Mar 20162:30 pmRNSAppointment of Joint Broker
16th Mar 20167:00 amRNSTrading Update
11th Mar 20167:00 amRNSAgreement with the United States Army
19th Jan 20167:00 amRNSGrant of options
11th Jan 20167:00 amRNSJoseph A. Cucolo to join Rex Bionics Board
9th Dec 20156:04 pmRNSGrant of options
8th Dec 20157:00 amRNSInterim Results for 6 months ending 30 Sept 2015
27th Nov 20157:00 amRNSRex Bionics Positive Interim Data from RAPPER II
12th Oct 20157:00 amRNSRex Bionics Plc - Company Update
18th Sep 20157:00 amRNSLegal cases providing funding for REX
28th Aug 20157:00 amRNSResult of AGM
11th Aug 20159:54 amRNSHolding(s) in Company
10th Aug 20152:30 pmRNSHolding(s) in Company
4th Aug 20157:01 amRNSNew RexLink Software captures Robot Movement Data
20th Jul 20157:00 amRNSAnnouncement of partnership agreement with MAAB
8th Jul 20154:00 pmRNSTR-1: NOTIFICATION OF MAJOR INTEREST IN SHARES
30th Jun 201511:31 amRNSResult of EGM
12th Jun 201511:06 amRNSProposed Fundraising and Notice of General Meeting
1st Jun 20157:00 amRNSFirst Patient Treated in RAPPER II Clinical Trial
29th May 20156:36 pmRNSCORRECTION Audited Results period ended31 Mar 2015
29th May 20154:25 pmRNSAudited results for period ending 31 Mar 2015
15th May 20157:00 amRNSRex announces Distribution Agreements in Europe
14th May 201510:00 amRNSREX to showcase at ISCoS and ASIA, Montreal
6th May 20157:02 amRNSMemorandum of Understanding signed
22nd Apr 20157:06 amRNSRex Bionics plc & Deltason establish partnership
15th Apr 20157:00 amRNSUpcoming Presentations to Private Investors
12

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.